Drug
Hexaminolevulinate hydrochloride clinical trials
Also written Hexvix, hexaminolevulinate and Cysview.
- studies test it
- 20
- open now
- 3
- in phase 3
- 8
- first study started
- 2001
Keep track of what changes. Save the hexaminolevulinate hydrochloride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
20 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 9
- Phase 3
- 8
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 8
Photocure (11) · Joint Authority for Päijät-Häme Social and Health Care (1) · Oslo University Hospital (1) · Edward Messing (1) · Jørgen Bjerggaard Jensen (1) · Tongji Hospital (1) · University of Roma La Sapienza (1) · Johns Hopkins University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses hexaminolevulinate hydrochloride is read from its arms, and is right about nine times in ten.
Testing it · 20
- Exploratory Study of the Efficacy of HAL-PDT in CIN 3Not yet recruitingPhase 2Tongji HospitalNCT07891338Written as Hexaminolevulinate (HAL)
- Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)RecruitingPhase 4University of Roma La SapienzaNCT05962541Written as PDD-TURBT with hexaminolevulinate (Hexvix®)
- Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light ResectionRecruitingPhase 3Johns Hopkins UniversityNCT06525571Written as Cysview
- Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder CancerCompletedPhase 3PhotocureNCT05600322Written as Hexaminolevulinate Hydrochloride
- Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDTCompletedPhase 2/3Oslo University HospitalNCT01282515Written as hexaminolevulinate
- The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic DiagnosticsWithdrawnPhase 2Dr. Te VuongNCT03272659Written as Cysview
- Near Infrared Fluorescence Imaging for Bladder Cancer DetectionCompletedNot applicableEdward MessingNCT03058705Written as Hexaminolevulinate HCL
- Photodynamic Diagnosis (PDD) in Flexible CystoscopyCompletedPhase 3Jørgen Bjerggaard JensenNCT02660190Written as hexaminoavolunate
- Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MALActive, not recruitingPhase 1/2Joint Authority for Päijät-Häme Social and Health CareNCT02367547Written as Hexylaminolevulinate cream
- A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance SettingCompletedPhase 3PhotocureNCT02560584Written as Hexaminolevulinate hydrochloride
- Recurrence of Bladder Cancer After Transurethral Resection With HexvixWithdrawnPhase 4GE HealthcareNCT00785694Written as hexaminolevulinate
- Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder CancerCompletedPhase 3PhotocureNCT00052637Written as hexaminolevulinate
- An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the ColonTerminatedPhase 1/2PhotocureNCT01344902Written as hexaminolevulinate HCl
- Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence CystoscopyCompletedPhase 3PhotocureNCT00233402Written as Hexvix
- A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder CancerCompletedPhase 3PhotocureNCT00412971Written as Hexvix
- Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1TerminatedPhase 2PhotocureNCT00708942Written as Hexaminolevulinate (HAL)
- Detection of Bladder Tumors After 30 Min Instillation of HexvixTerminatedPhase 2PhotocureNCT01551407Written as Hexvix
- A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.CompletedPhase 1/2PhotocureNCT00369018Written as methyl aminolevulinate (MAL) and hexaminolevulinate (HAL)
- Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding StudyCompletedPhase 1/2PhotocureNCT00285701Written as hexaminolevulinate
- An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female VolunteersCompletedPhase 1PhotocureNCT01050309Written as hexaminolevulinate (HAL)
Codes
What other systems call hexaminolevulinate hydrochloride · ClinicalTrials.gg INT004302
- MeSH (NLM) C4199245-aminolevulinic acid hexyl esterConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) D4F329SL1OHEXAMINOLEVULINATE HYDROCHLORIDEConfirmed FDA, Wikidata
- RxNorm 1426871Confirmed FDA, Wikidata
- Wikidata Q27276092hexaminolevulinate hydrochlorideConfirmed FDA, Wikidata
- NCI Thesaurus C73601Hexaminolevulinate HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C419924 | 5-aminolevulinic acid hexyl ester | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | D4F329SL1O | HEXAMINOLEVULINATE HYDROCHLORIDE | Confirmed FDA, Wikidata |
| RxNorm | 1426871 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27276092 | hexaminolevulinate hydrochloride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C73601 | Hexaminolevulinate Hydrochloride | One source FDA |
Also registered as hexaminolevulinate (UNII G7H20TKI67 · RxNorm 1426872).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.